Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Long-term low-dose warfarin use is effective in the prevention of recurrent venous thromboembolism: yes.

Ridker PM.

J Thromb Haemost. 2004 Jul;2(7):1034-7. No abstract available.

3.

Initiating warfarin therapy: 5 mg versus 10 mg.

Eckhoff CD, Didomenico RJ, Shapiro NL.

Ann Pharmacother. 2004 Dec;38(12):2115-21. Epub 2004 Nov 2. Review.

PMID:
15522981
4.

Update in thrombosis: answers to perplexing questions.

Federman DG, Brescia GR, Moriarty JP, Haskell SG, Krishnamurthy R, Kirsner RS.

Cleve Clin J Med. 2005 Oct;72(10):907-15. Review.

PMID:
16231687
5.

Emerging options in the treatment of venous thromboembolism.

Nutescu EA.

Am J Health Syst Pharm. 2004 Dec 1;61(23 Suppl 7):S12-7. Review.

PMID:
15597574
6.

Long-term anticoagulation prophylaxis following acute thromboembolism.

Hyers TM.

Dis Mon. 2005 Feb-Mar;51(2-3):158-65. Review. No abstract available.

PMID:
15900268
7.

Treatment of DVT: how long is enough and how do you predict recurrence.

Agnelli G, Becattini C.

J Thromb Thrombolysis. 2008 Feb;25(1):37-44. Epub 2007 Oct 1. Review.

PMID:
17906973
8.

Duration of anticoagulants in acute or recurrent venous thromboembolism.

Schulman S.

Curr Opin Pulm Med. 2000 Jul;6(4):321-5. Review.

PMID:
10912640
9.

Low dose.

Shrivastava S, Ridker PM.

Clin Adv Hematol Oncol. 2005 Nov;3(11):880-1. Review. No abstract available.

PMID:
16491634
10.

Issues in anticoagulant therapy: recent trials start to answer the tough questions.

Jaffer AK.

Cleve Clin J Med. 2005 Feb;72(2):157-63. Review.

PMID:
15757171
11.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
12.

Standard-intensity vs low-dose anticoagulation for long-term management of patients with venous thromboembolism.

Lazo-Langner A, Kovacs MJ.

Clin Adv Hematol Oncol. 2005 Nov;3(11):877-9. Review. No abstract available.

PMID:
16491633
13.

The safety of fondaparinux for the prevention and treatment of venous thromboembolism.

Turpie AG.

Expert Opin Drug Saf. 2005 Jul;4(4):707-21. Review.

PMID:
16011449
14.

[There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].

Schulman S.

Lakartidningen. 2003 Jun 12;100(24):2118-21. Review. Swedish. No abstract available.

PMID:
12841107
15.

Prophylaxis and treatment of venous thromboembolism in patients with cancer.

Ageno W, Squizzato A.

Intern Emerg Med. 2006;1(4):260-2. Review. No abstract available.

PMID:
17217144
16.

Appropriate level and length of postthrombotic warfarin treatment: an evaluation of recent developments.

ten Cate-Hoek AJ, Prins MH.

Curr Opin Hematol. 2004 May;11(3):182-6. Review.

PMID:
15257018
17.

Low-molecular-weight heparin for the treatment of venous thromboembolism in the elderly.

Pineo GF, Hull RD.

Clin Appl Thromb Hemost. 2005 Jan;11(1):15-23. Review.

PMID:
15678269
18.

Management of venous thromboembolism in the elderly.

Spyropoulos AC, Merli G.

Drugs Aging. 2006;23(8):651-71. Review.

PMID:
16964988
19.

Clearing the way: treating venous thromboembolism and deep vein thrombosis.

Lambing A.

Adv Nurse Pract. 2005 Jun;13(6):24-30; quiz 31. Review. No abstract available.

PMID:
15984353
20.

Insufficient evidence supporting low-intensity warfarin for venous thromboembolism (VTE) prophylaxis.

Cundiff DK.

MedGenMed. 2003 Jul 2;5(3):2. Review. No abstract available.

Supplemental Content

Support Center